Abstract
Background: Dolutegravir is highly effective, with a high genetic barrier to HIV grug resistance , and is well tolerated. International studies have assessed the efficacy and non-inferiority of dolutegravir, but more studies are required to assess its clinical effectiveness in resource-constrained settings……………….
…………………………………………………………………………………………………………………………………………………………………